Introduction
============

Hemocyanin is a large molecule and copper-containing protein and carries oxygen to peripheral tissues in mollusk and arthropod circulation (Amkraut et al., 1969\[[@R1]\]). Some of hemocyanins such as *Concholepas concholepas* hemocyanin (De Ioannes et al., 2004\[[@R12]\]; Moltedo et al., 2006\[[@R35]\]), *Fissurella latimarginata* hemocyanin (Arancibia et al., 2014\[[@R2]\]) and *Megathura crenulata* hemocyanin have been used as a hapten carrier to produce antibodies (Becker et al., 2014\[[@R4]\]). The marine mollusk *M. crenulata* hemocyanin is commonly known as a keyhole limpet hemocyanin (KLH). KLH is composed of two subunits of approximately 360,000 - 400,000 in monomeric molecular weight (Markl et al., 1991\[[@R31]\]) and well known as an immunostimulant in mammals including human for more than 40 years (Curtis et al., 1970\[[@R11]\], 1971\[[@R10]\]; Herscowitz et al., 1972\[[@R19]\]; Weigle, 1964\[[@R50]\]). However, the initial physiological responses to KLH and direct effects of KLH on the innate immune systems are not clear.

The innate immune system plays an important role in host defense against many pathogens. Pathogen-associated molecular patterns (PAMPs) are detected through specific pattern recognition receptors (PRRs) (Janeway and Medzhitov, 2002\[[@R20]\]; Medzhitov and Janeway, 1997\[[@R32]\]; Mogensen, 2009\[[@R34]\]), which include toll like receptors (TLRs) and C-type lectin receptors (CLRs) (Drummond et al., 2011\[[@R14]\]). The important roles in host defense are production of inflammatory mediators and phagocytosis. For example, a gram-negative pathogen *Francisella tularensis* is recognized by PRRs, leading to the production of inflammatory mediators through the activation of mitogen-activated protein kinases (MAPK) and nuclear factor-kappa B (NF-κB) (Golovliov et al., 1996\[[@R17]\]; Stenmark et al., 1999\[[@R47]\]; Parsa et al., 2006\[[@R39]\]; Butchar et al., 2007\[[@R7]\]). The host cell receptors, including complement receptor 3 (CR3) (Ben Nasr et al., 2006\[[@R5]\]; Clemens et al., 2005\[[@R9]\]), mannose receptor (MR) (Balagopal et al., 2006\[[@R3]\]), toll like receptor 2 (TLR2) (Katz et al., 2006\[[@R22]\]; Malik et al., 2006\[[@R29]\]) and Fcγ receptors (FcγRs) (Balagopal et al., 2006\[[@R3]\]) are implicated in the recognition of *F. tularensis*. These receptors in myeloid cell mainly activate the downstream signaling pathways via spleen tyrosine kinase (Syk) (Osorio and Reis e Sousa, 2011\[[@R37]\]). Syk is one of the common molecules associated with these receptors (Kerrigan and Brown, 2010\[[@R23]\]; Hadas et al., 2012\[[@R18]\]; Dennehy et al., 2008\[[@R13]\]; Falker et al., 2014\[[@R15]\]). The study on *F. tularensis* phagocytosis also reported that Syk-dependent phagocytosis was controlled through an extracellular signal-regulated kinase (Erk) pathway (Parsa et al., 2008\[[@R38]\]). Erk is a member of the MAPK family and the MAPK cascades involve in the regulation of cell proliferation, survival and differentiation (Roberts and Der, 2007\[[@R42]\]). The MAPK pathways relay intracellular signals and elicit physiological responses such as inflammatory responses and apoptosis in mammalian cells (Roux and Blenis, 2004\[[@R44]\]; Zhang and Liu, 2002\[[@R52]\]). Several studies reported that Erk was a downstream component of many signaling pathways with various receptors, such as CR3 (Li et al., 2014\[[@R27]\]), MR (Tsai et al., 2013\[[@R48]\]), TLR2 (Richardson et al., 2015\[[@R41]\]; Chen et al., 2015\[[@R8]\]) and FcγRs (Luo et al., 2010\[[@R28]\]; Song et al., 2004\[[@R46]\]).

In this study, we have evaluated the effects of a Syk specific inhibitor on KLH-induced NF-κB activation and Erk activation in the human monocyte leukemia cell line THP-1. We then discussed about the roles of Syk and Erk in innate immune responses of THP-1 to KLH.

Materials and Methods
=====================

Antibodies and reagents
-----------------------

Mariculture keyhole limpet hemocyanin was purchased from Thermo Fisher Scientific (Rockford, IL). Ammonium pyrrolidinedithiocarbamate (PDTC) and *Echerichia coli* LPS were purchased from Sigma-Aldrich (St. Louis, MO). Syk inhibitor (Bay 61-3606 hydrochloride), Erk inhibitor (Nimble) and anti-Erk1/2 antibody (EPR 17526) were purchased from Abcam (Tokyo). Anti-phospho-Erk1/2 (Tyr 202/204) antibody was purchased from Cell Signaling Technology (Danvers, MA).

Cell culture
------------

THP-1 cells were obtained from Japanese Collection of Research Bioresources Cell Bank (Osaka) and grown in an RPMI medium (Thermo Fisher Scientific, Waltham, MA) supplemented with 10 % (vol/vol) fetal bovine serum (Thermo Fisher Scientific), 1 % (vol/vol) GlutaMAX™ Supplement (Thermo Fisher Scientific), and 100 μg/ml Normocin™ (InvivoGen, Sandiego, CA) at 37° C with 5 % CO~2~. THP1-Xblue™-MD2-CD14 cells were acquired from InvivoGen and grown in an RPMI medium supplemented with 10 % fetal bovine serum, 100 μg/ml Normocin™ (InvivoGen), 200 μg/ml Zeocin™ (InvivoGen) and 250 μg/ml G418 (InvivoGen) at 37° C with 5 % CO~2~. THP1-Xblue™-MD2-CD14 cells contain the secreted embryonic alkaline phosphatase (SEAP) reporter gene under controls of NF-κB and/or activator protein-1 (AP-1).

Measurement of NF-κB and/or AP-1 activity using THP1-XBlue™-MD2-CD14 cells
--------------------------------------------------------------------------

THP1-XBlue™-MD2-CD14 cells (5 × 10^5^ cells) were seeded at 96 well plate and then stimulated with 0.1 µg/ml LPS (positive control) or 50 µg/ml KLH for 24 h. Supernatants were collected and incubated with QUANTI-Blue™ (InvivoGen) for 24 h, which turns purple in the presence of secreted alkaline phosphatase (SEAP). SEAP levels were determined spectrophotometrically at 650 nm.

Western Blot Analyses
---------------------

THP-1 cells (1 × 10^7^ cells) were stimulated with 0.1 µg/ml LPS or 500 µg/ml KLH at 37° C for various periods. At the end of the incubation period, cells were lysed in a RIPA buffer (20 mM Tris-HCl \[pH 7.5\], 150 mM NaCl, 1 mM disodium ethylene-diaminotetraacetate \[Na~2~EDTA\], 1 mM ethylene glycol tetraacetic acid \[EGTA\], 1 % Nonidet P-40 \[NP-40\], 1 % sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na~3~VO~4~, 1 µg/ml leupeptin, Protease Inhibitor Cocktail \[Nakarai Tesque, Tokyo\], 1 mM NaF and 1 mM phenylmethylsulfonyl fluoride \[PMSF\]) for 30 min on ice. After centrifugation (20,000 *g*, 10 min, 4° C), supernatant protein samples were separated by SDS-PAGE and transferred onto PVDF membranes (Bio-Rad Laboratories, CA), blocked with an Odyssey Blocking Buffer (IL-COR, Lincoln, NE). The membrane was incubated with the appropriate antibodies 1:600 (vol/vol) in the Odyssey Blocking Buffer with 0.2 % (vol/vol) Tween 20, followed by an incubation with a goat anti-rabbit IgG Alexa Fluor 680 secondary antibodies (Thermo Fisher Scientific, diluted at 3:10,000) in the Odyssey Blocking Buffer. The stained protein bands were digitally detected in an Odyssey Fc Dual-Mode Imaging System (IL-COR, Lincoln, NE).

Statistical analyses
--------------------

Each experiment was repeated at least three times. Results were expressed as mean ± standard deviation (SD). Data were assessed with one way ANOVA, followed by Student\'s t-test or Dunnet\'s multiple comparison test, and considered significantly different at *P*\< 0.05.

Results
=======

Effects of KLH on the NF-κB and/or AP-1 activities in THP-1 reporter cells
--------------------------------------------------------------------------

NF-κB and/or AP-1 were slightly activated in the control THP1-XBlue™ -MD2-CD14 cells probably due to a serial culture passage of cells (Figure 1[(Fig. 1)](#F1){ref-type="fig"}). The administration of LPS strongly activated NF-κB and/or AP-1 compared to the case in the control medium. An NF-κB inhibitor PDTC suppressed the activation induced by LPS. The administration of KLH markedly activated NF-κB and/or AP-1 as much as LPS, and PDTC also suppressed the KLH-induced activation.

Syk inhibitor partially suppressed the KLH- induced NF-κB activation
--------------------------------------------------------------------

Syk is deeply involved in several innate immune receptors (Dennehy et al., 2008\[[@R13]\]; Robinson et al., 2009\[[@R43]\]; Sancho et al., 2009\[[@R45]\]; Kerrigan and Brown, 2010\[[@R23]\], 2011\[[@R24]\]). In THP1-XBlue™-MD2-CD14 cells, a Syk inhibitor, Bay 61-3606 hydrochloride, partially inhibited the KLH-induced NF-κB activation (Figure 2[(Fig. 2)](#F2){ref-type="fig"}).

Erk inhibitor suppressed the KLH-induced NF-κB activation
---------------------------------------------------------

In THP1-Xblue™-MD2-CD14 cells, an Erk inhibitor, Nimble, obviously inhibited KLH-induced NF-κB activation (Figure 3[(Fig. 3)](#F3){ref-type="fig"}).

Syk inhibitor partially suppressed the Erk phosphorylation in KLH-stimulated THP-1
----------------------------------------------------------------------------------

Evaluated through Western blot with specific antibodies, anti-Erk1/2 antibody (EPR 17526) and anti-phospho-Erk1/2 (Tyr 202/204), it is suggested that Erk should be phosphorylated by KLH stimulation. The phosphorylation ratio significantly increased in a time-dependent manner. The peak of Erk phosphorylation was observed at 2 min after KLH stimulation and then the phosphorylated Erk decreased by 10 min after KLH stimulation.

In contrast, in THP-1 cells treated with the Syk inhibitor, the phosphorylation ratio did not increase compared to the case of non-treated THP-1 cells, suggesting that the KLH-induced Erk phosphorylation was partially suppressed by the Syk inhibitor (Figure 4[(Fig. 4)](#F4){ref-type="fig"}).

Discussion
==========

In this study, we have in part clarified the initial responses to KLH and direct effects of KLH on the innate immune systems in human monocytic cells. We have found that KLH activates NF-κB as much as LPS in the THP-1 cells and that the KLH-induced NF-κB activation is partially mediated via Syk and Erk pathways in human monocytic THP-1 cells. The NF-κB inhibitor, PDTC, suppresses the release of the inhibitory subunit IκB from the latent cytoplasmic form of NF-κB and does not influence the other DNA binding activities including AP-1 (Robinson et al., 2009\[[@R43]\]). PDTC markedly suppressed the KLH-induced activation of the NF-κB/AP-1 reporter cells, suggesting that the activation should be triggered by NF-κB. The transcription factor, NF-κB, plays crucial roles in the immune system (Ghosh et al., 1998\[[@R16]\]; Li and Verma, 2002\[[@R26]\]; Bonizzi and Karin, 2004\[[@R6]\]). We have then investigated signaling pathways from KLH reception to NF-κB activation in THP-1 monocyte.

Presicce et al. (2008\[[@R40]\]) reported that KLH-induced activation and maturation of monocyte-derived dendritic cells (DCs) were partially mediated via one of lectin receptors, mannose receptor (MR). Mansour et al. (2006\[[@R30]\]) stated that mannose was important for MR-mediated endocytosis of monocyte-derived DCs. The KLH-induced NF-κB activation observed in this study might therefore have a certain association with a lectin receptor, probably because KLH was rich in mannose. The lectin receptors and other receptors, such as MR (Tsai et al., 2013\[[@R48]\]), CR3 (Xia et al., 1999\[[@R51]\]), TLRs (Netea et al., 2006\[[@R36]\]) and FcγRs (Vogelpoel et al., 2015\[[@R49]\]), drive Syk signaling cascades (Kerrigan et al., 2010\[[@R23]\]; Hadas et al., 2012\[[@R18]\]; Dennehy et al., 2008\[[@R13]\]; Falker et al., 2014\[[@R15]\]), leading to Syk autophosphorylation and NF-κB activation. The NF-κB activation results in the production of pro-inflammatory cytokines, which in turn induces cellular responses, including apoptosis and phagocytosis (Parsa et al., 2008\[[@R38]\]; Kingeter and Lin, 2012\[[@R25]\]; Falker et al., 2014\[[@R15]\]). In the present study, a Syk inhibitor, Bay 61-3606 hydrochloride, partially suppressed the KLH-induced NF-κB activation, suggesting that Syk would partially associate with the signaling pathways.

Erk has an important role of fundamental cellular reaction such as differentiation (Falker et al., 2014\[[@R15]\]), inflammatory responses (Roux and Blenis, 2004\[[@R44]\]; Zhang and Liu, 2002\[[@R52]\]) and apoptosis in mammalian cells (Parsa et al., 2008\[[@R38]\]; Roberts and Der, 2007\[[@R42]\]). Several studies reported that Erk was in downstream of these receptors, CR3(Li et al., 2014\[[@R27]\]), MR (Tsai et al., 2013\[[@R48]\]), TLR2 (Richardson et al., 2015\[[@R41]\]; Chen et al., 2015\[[@R8]\]) and FcγRs (Luo et al., 2010\[[@R28]\]; Song et al., 2004\[[@R46]\]). Many reports about phagocytosis mentioned that Erk had an important role in the phagocytosis of pathogenic organisms (Song et al., 2004\[[@R46]\]; Balagopal et al., 2006\[[@R3]\]; Parsa et al., 2008\[[@R38]\]) and that Syk promoted the phagocytosis of *F. tularensis* via Erk pathway (Parsa et al., 2008\[[@R38]\]). We demonstrated that an Erk inhibitor, Nimble, suppressed the KLH-induced NF-κB activation and that the KLH-induced Erk phosphorylation was partially suppressed by a Syk inhibitor. These results suggest that Erk would be located in downstream of Syk and upstream of NF-κB signaling pathways (Miyazaki et al., 2000\[[@R33]\]; Jiang et al., 2004\[[@R21]\]).

Syk and some Syk-related receptors are partially involved in the KLH-induced NF-κB activation and the KLH-induced Erk phosphorylation. It is necessary to identify KLH receptor(s) and the associated molecule(s) in order to understand the KLH-induced NF-κB activation mechanisms comprehensively. We are now further investigating the signaling cascades along these lines.

![Effects of PDTC on the KLH-induced NF-κB activation. THP-1 reporter cell (THP1-XBlue™-MD2-CD14 Cells) was stimulated with 0.1 µg/ml LPS or 50 µg/ml KLH in the presence or the absence of 10 µM PDTC. Values represent mean ± SD of six assays. Significant differences from RPMI (negative control) values were defined as \*P \< 0.05 (one-way ANOVA and Dunnett\'s test), \*\*P \< 0.0001 (one-way ANOVA and Student\'s t-test).](EXCLI-15-474-g-001){#F1}

![Effects of Syk inhibitor on the KLH-induced NF-κB activation. THP-1 reporter cell was stimulated with 0.1 µg/ml LPS or 50 µg/ml KLH in the presence or the absence of 1 µM Syk inhibitor (Bay 61-3606). Values represent mean ± SD of six assays.\
\*\*Significantly different from values in the absence of the inhibitor, P \< 0.0001 (one-way ANOVA and Student\'s t-test).](EXCLI-15-474-g-002){#F2}

![Effects of Erk inhibitor on the KLH-induced NF-κB activation. THP-1 reporter cell was stimulated with 0.1 µg/ml LPS or 50 µg/ml KLH in the presence or the absence of 5 µM Erk inhibitor (Nimbolide). Values represent mean ± SD of six assays.\
\*\*Significantly different from values in the absence of the inhibitor, P \< 0.0001 (one-way ANOVA and Student\'s t-test).](EXCLI-15-474-g-003){#F3}

![Effects of Syk inhibitor on the KLH-induced Erk phosphorylation. (A) THP-1 cells were pre-treated or non-treated 10 µM Syk inhibitor (Bay 61-3606) at 37° C for two hours. THP-1 cells were then stimulated with 500 µg/ml KLH at 37° C for various periods of time. At the end of the incubation period, cells were lysed in a RIPA buffer with inhibitors for 30 min on ice. After centrifugation (20,000 g, 10 min, 4° C), supernatant proteins were evaluated through the Western blot with antibodies, anti-Erk1/2 antibody (EPR 17526) and anti-phospho-Erk1/2 (Tyr 202/204). (B) Phosphorylation signals were normalized to total Erk1/2 signal intensities in the panel (A). The graphs represent mean ± SD of values obtained from three independent experiments.\
\*Significantly different from the initial value in the absence of the inhibitor, \*P \< 0.05 (one-way ANOVA and Dunnett\'s test). †There is a significant difference between values with and without the inhibitor at 2 min, †P \< 0.001 (one-way ANOVA and Student\'s t-test).](EXCLI-15-474-g-004){#F4}
